A detailed history of Virtu Financial LLC transactions in Merus N.V. stock. As of the latest transaction made, Virtu Financial LLC holds 18,399 shares of MRUS stock, worth $1.77 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
18,399
Previous 4,427 315.61%
Holding current value
$1.77 Million
Previous $233,000 643.35%
% of portfolio
0.1%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$52.33 - $94.15 $731,154 - $1.32 Million
13,972 Added 315.61%
18,399 $1.73 Million
Q2 2025

Aug 12, 2025

BUY
$34.89 - $62.42 $154,458 - $276,333
4,427 New
4,427 $233,000
Q1 2024

May 20, 2024

BUY
$28.03 - $51.82 $345,357 - $638,474
12,321 New
12,321 $555,000

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $4.4B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.